TheEdgeResearch
Home / Stocks / SYGGF

Synairgen plc (SYGGF)

OTC Healthcare Biotechnology
$0.00 ▲ +0.00%
Market Cap
$110,266
Sector
Healthcare
Industry
Biotechnology
Beta
7.41
52-Wk Range
0.00001-0.0141
CEO
Joseph Tregonning Colliver
Country
GB
Currency
USD

Synairgen plc operates in the Biotechnology industry of the Healthcare sector, headquartered in Southampton, LO, GB. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $110,266. On trailing twelve-month figures it carries a trailing P/E of -0.23, a net margin of 0.0%. Its beta of 7.41 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.23
Price / Sales
0.00
Price / Book
0.15
EV / EBITDA
-0.11
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
0.00
Current ratio
9.01
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
34
IPO date
2020-07-20
Headquarters
Southampton, LO, GB
About Synairgen plc

Synairgen plc specializes in the research and development of pharmaceutical treatments for various respiratory conditions. Its product pipeline includes SNG001, an inhaled interferon beta currently being developed for COVID-19. The company is also advancing an inhaled form of interferon beta (IFN-ß) through Phase II clinical trials for the management of asthma triggered by common colds and influenza, as well as for the treatment or prevention of chronic obstructive pulmonary disease. Furthermore, Synairgen is developing a LOXL2 inhibitor intended for treating idiopathic pulmonary fibrosis (IPF). To support the development of this LOXL2 inhibitor, the company maintains a licensing and collaboration agreement with Pharmaxis Ltd. Synairgen plc was established in 2004 and is headquartered in Southampton, United Kingdom.

Comparable companies

Synairgen plc is most often compared with the following Healthcare names:

ACMSYCLCSGLABFIMMVFIMUCPPCBQPTFFSRBCFTELIFZHCLF
More research on SYGGF
SYGGF technical analysis SYGGF TheEdge Score Compare against peers
Open full interactive analysis & DCF →